- call +1-201-465-4211
- email sales@mrinsights.biz
Intramuscular injector is an injecting device used to delivering medications deep into the muscles. At present, intramuscular injectors are used in modern medicine to enable quick absorption of medication in the bloodstream. Generally, these injectors are used to deliver vaccines and drugs. In addition, these are highly preferred to other drug delivery routes for quick treatment, as muscle tissues have higher blood supply as compared to the tissues present under the skin and muscles are capable of holding high volume of medication.
Scope of the Report:
The global intramuscular injectors market is driven by growth in prevalence of chronic diseases that require medications through muscles, rise in demand for biosimilars and vaccination, and increased demand for drug delivery due to its advantages.
The worldwide market for Intramuscular Injector is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Intramuscular Injector in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Antares Pharma Inc
Endo International Plc
Bioject Medical Technologies Inc
PharmaJetMedical International Technology
National Medical Products
Valeritas
European Pharma Group
PenJet Corporation
Becton
Dickinson
Injex Pharma AG
Crossject SA
Solace Biotech
Sanify Healthcare Private Limited
Novosanis
Vata, Inc
Kaleo, Inc
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Pre-fillable Injection System
Fillable Needle-free Injectors
Market Segment by Applications, can be divided into
Hospitals
Clinics
Ambulatory Surgery Centers
Others
There are 15 Chapters to deeply display the global Intramuscular Injector market.
Chapter 1, to describe Intramuscular Injector Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Intramuscular Injector, with sales, revenue, and price of Intramuscular Injector, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Intramuscular Injector, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Intramuscular Injector market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Intramuscular Injector sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Intramuscular Injector Introduction
1.2 Market Analysis by Type
1.2.1 Pre-fillable Injection System
1.2.2 Fillable Needle-free Injectors
1.3 Market Analysis by Applications
1.3.1 Hospitals
1.3.2 Clinics
1.3.3 Ambulatory Surgery Centers
1.3.4 Others
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Antares Pharma Inc
2.1.1 Business Overview
2.1.2 Intramuscular Injector Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Antares Pharma Inc Intramuscular Injector Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Endo International Plc
2.2.1 Business Overview
2.2.2 Intramuscular Injector Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Endo International Plc Intramuscular Injector Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Bioject Medical Technologies Inc
2.3.1 Business Overview
2.3.2 Intramuscular Injector Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Bioject Medical Technologies Inc Intramuscular Injector Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 PharmaJetMedical International Technology
2.4.1 Business Overview
2.4.2 Intramuscular Injector Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 PharmaJetMedical International Technology Intramuscular Injector Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 National Medical Products
2.5.1 Business Overview
2.5.2 Intramuscular Injector Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 National Medical Products Intramuscular Injector Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Valeritas
2.6.1 Business Overview
2.6.2 Intramuscular Injector Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Valeritas Intramuscular Injector Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 European Pharma Group
2.7.1 Business Overview
2.7.2 Intramuscular Injector Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 European Pharma Group Intramuscular Injector Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 PenJet Corporation
2.8.1 Business Overview
2.8.2 Intramuscular Injector Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 PenJet Corporation Intramuscular Injector Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Becton
2.9.1 Business Overview
2.9.2 Intramuscular Injector Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Becton Intramuscular Injector Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Dickinson
2.10.1 Business Overview
2.10.2 Intramuscular Injector Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Dickinson Intramuscular Injector Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Injex Pharma AG
2.11.1 Business Overview
2.11.2 Intramuscular Injector Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Injex Pharma AG Intramuscular Injector Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Crossject SA
2.12.1 Business Overview
2.12.2 Intramuscular Injector Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Crossject SA Intramuscular Injector Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Solace Biotech
2.13.1 Business Overview
2.13.2 Intramuscular Injector Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Solace Biotech Intramuscular Injector Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Sanify Healthcare Private Limited
2.14.1 Business Overview
2.14.2 Intramuscular Injector Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Sanify Healthcare Private Limited Intramuscular Injector Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Novosanis
2.15.1 Business Overview
2.15.2 Intramuscular Injector Type and Applications
2.15.2.1 Product A
2.15.2.2 Product B
2.15.3 Novosanis Intramuscular Injector Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Vata, Inc
2.16.1 Business Overview
2.16.2 Intramuscular Injector Type and Applications
2.16.2.1 Product A
2.16.2.2 Product B
2.16.3 Vata, Inc Intramuscular Injector Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 Kaleo, Inc
2.17.1 Business Overview
2.17.2 Intramuscular Injector Type and Applications
2.17.2.1 Product A
2.17.2.2 Product B
2.17.3 Kaleo, Inc Intramuscular Injector Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Intramuscular Injector Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Intramuscular Injector Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Intramuscular Injector Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Intramuscular Injector Manufacturer Market Share in 2017
3.3.2 Top 6 Intramuscular Injector Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Intramuscular Injector Market Analysis by Regions
4.1 Global Intramuscular Injector Sales, Revenue and Market Share by Regions
4.1.1 Global Intramuscular Injector Sales and Market Share by Regions (2013-2018)
4.1.2 Global Intramuscular Injector Revenue and Market Share by Regions (2013-2018)
4.2 North America Intramuscular Injector Sales and Growth Rate (2013-2018)
4.3 Europe Intramuscular Injector Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Intramuscular Injector Sales and Growth Rate (2013-2018)
4.5 South America Intramuscular Injector Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Intramuscular Injector Sales and Growth Rate (2013-2018)
5 North America Intramuscular Injector by Countries
5.1 North America Intramuscular Injector Sales, Revenue and Market Share by Countries
5.1.1 North America Intramuscular Injector Sales and Market Share by Countries (2013-2018)
5.1.2 North America Intramuscular Injector Revenue and Market Share by Countries (2013-2018)
5.2 United States Intramuscular Injector Sales and Growth Rate (2013-2018)
5.3 Canada Intramuscular Injector Sales and Growth Rate (2013-2018)
5.4 Mexico Intramuscular Injector Sales and Growth Rate (2013-2018)
6 Europe Intramuscular Injector by Countries
6.1 Europe Intramuscular Injector Sales, Revenue and Market Share by Countries
6.1.1 Europe Intramuscular Injector Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Intramuscular Injector Revenue and Market Share by Countries (2013-2018)
6.2 Germany Intramuscular Injector Sales and Growth Rate (2013-2018)
6.3 UK Intramuscular Injector Sales and Growth Rate (2013-2018)
6.4 France Intramuscular Injector Sales and Growth Rate (2013-2018)
6.5 Russia Intramuscular Injector Sales and Growth Rate (2013-2018)
6.6 Italy Intramuscular Injector Sales and Growth Rate (2013-2018)
7 Asia-Pacific Intramuscular Injector by Countries
7.1 Asia-Pacific Intramuscular Injector Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Intramuscular Injector Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Intramuscular Injector Revenue and Market Share by Countries (2013-2018)
7.2 China Intramuscular Injector Sales and Growth Rate (2013-2018)
7.3 Japan Intramuscular Injector Sales and Growth Rate (2013-2018)
7.4 Korea Intramuscular Injector Sales and Growth Rate (2013-2018)
7.5 India Intramuscular Injector Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Intramuscular Injector Sales and Growth Rate (2013-2018)
8 South America Intramuscular Injector by Countries
8.1 South America Intramuscular Injector Sales, Revenue and Market Share by Countries
8.1.1 South America Intramuscular Injector Sales and Market Share by Countries (2013-2018)
8.1.2 South America Intramuscular Injector Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Intramuscular Injector Sales and Growth Rate (2013-2018)
8.3 Argentina Intramuscular Injector Sales and Growth Rate (2013-2018)
8.4 Colombia Intramuscular Injector Sales and Growth Rate (2013-2018)
9 Middle East and Africa Intramuscular Injector by Countries
9.1 Middle East and Africa Intramuscular Injector Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Intramuscular Injector Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Intramuscular Injector Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Intramuscular Injector Sales and Growth Rate (2013-2018)
9.3 UAE Intramuscular Injector Sales and Growth Rate (2013-2018)
9.4 Egypt Intramuscular Injector Sales and Growth Rate (2013-2018)
9.5 Nigeria Intramuscular Injector Sales and Growth Rate (2013-2018)
9.6 South Africa Intramuscular Injector Sales and Growth Rate (2013-2018)
10 Global Intramuscular Injector Market Segment by Type
10.1 Global Intramuscular Injector Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Intramuscular Injector Sales and Market Share by Type (2013-2018)
10.1.2 Global Intramuscular Injector Revenue and Market Share by Type (2013-2018)
10.2 Pre-fillable Injection System Sales Growth and Price
10.2.1 Global Pre-fillable Injection System Sales Growth (2013-2018)
10.2.2 Global Pre-fillable Injection System Price (2013-2018)
10.3 Fillable Needle-free Injectors Sales Growth and Price
10.3.1 Global Fillable Needle-free Injectors Sales Growth (2013-2018)
10.3.2 Global Fillable Needle-free Injectors Price (2013-2018)
11 Global Intramuscular Injector Market Segment by Application
11.1 Global Intramuscular Injector Sales Market Share by Application (2013-2018)
11.2 Hospitals Sales Growth (2013-2018)
11.3 Clinics Sales Growth (2013-2018)
11.4 Ambulatory Surgery Centers Sales Growth (2013-2018)
11.5 Others Sales Growth (2013-2018)
12 Intramuscular Injector Market Forecast (2018-2023)
12.1 Global Intramuscular Injector Sales, Revenue and Growth Rate (2018-2023)
12.2 Intramuscular Injector Market Forecast by Regions (2018-2023)
12.2.1 North America Intramuscular Injector Market Forecast (2018-2023)
12.2.2 Europe Intramuscular Injector Market Forecast (2018-2023)
12.2.3 Asia-Pacific Intramuscular Injector Market Forecast (2018-2023)
12.2.4 South America Intramuscular Injector Market Forecast (2018-2023)
12.2.5 Middle East and Africa Intramuscular Injector Market Forecast (2018-2023)
12.3 Intramuscular Injector Market Forecast by Type (2018-2023)
12.3.1 Global Intramuscular Injector Sales Forecast by Type (2018-2023)
12.3.2 Global Intramuscular Injector Market Share Forecast by Type (2018-2023)
12.4 Intramuscular Injector Market Forecast by Application (2018-2023)
12.4.1 Global Intramuscular Injector Sales Forecast by Application (2018-2023)
12.4.2 Global Intramuscular Injector Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Intramuscular Injector Picture
Table Product Specifications of Intramuscular Injector
Figure Global Sales Market Share of Intramuscular Injector by Types in 2017
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
